Todd Shegog - 07 Jun 2023 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Director
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
Issuer symbol
COGT
Transactions as of
07 Jun 2023
Net transactions value
$0
Form type
4
Filing time
08 Jun 2023, 16:43:58 UTC
Previous filing
14 Oct 2022
Next filing
13 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $0 +36,700 $0.000000 36,700 07 Jun 2023 Common Stock 36,700 $11.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders.